市場調查報告書
商品編碼
946289

殺菌過濾市場-成長,趨勢,預測(2020年∼2025年)

Sterile Filtration Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 117 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

殺菌過濾市場由於製藥公司和生物醫藥品公司成長與研究開發活動的投資增加,在2020年∼2025年的預測期間內,記錄為8%的年複合成長率。根據歐洲製藥產業聯合會,全球製藥產業整體銷售量約8億5264萬7000美元。還有過濾是藥品生產的重要組成部分。為了確保患者的安全,藥物應遠離有害細菌,病毒和其他微生物。

本報告提供殺菌過濾市場調查,市場概要,市場成長要素及阻礙因素分析,各產品、各終端用戶、各地區的市場規模的變化與預測,競爭情形,主要企業的簡介,市場機會等全面性資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 市場成長要素
    • 慢性病患的負擔增加
    • 醫藥品及生物醫藥品產業的崛起
  • 市場阻礙因素
    • 嚴格法規
  • 波特的五力分析

第5章 市場細分化

  • 各產品
    • 濾心式過濾器
    • 膠囊過濾器
    • 針筒過濾器
    • 過濾器
    • 配件
  • 各終端用戶
    • 製藥及生物醫藥品企業
    • 受託調查機關
    • 研究
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • 3M
    • Cole-Parmer Instrument Company, LLC
    • Danaher Corporation
    • Eaton Corporation
    • GE Healthcare
    • Merck KGaA
    • Sartorius AG
    • Porvair Filtration Group
    • Sterlitech Corporation
    • ThermoFisher Scientific Inc.

第7章 市場機會及未來趨勢

目錄
Product Code: 70529

The Sterile Filtration market is expected to register a CAGR of 8% over the forecast period, owing to the growing pharmaceutical and biopharmaceutical companies and increasing investments into research and development activities. According to the European Federation of Pharmaceutical Industries and Associations, the overall sales of pharmaceutical industry worldwide was recorded to be approximately 852,647 million USD. Furthermore, emission of high concentration of high antibiotics on the manufacturing sites that might develop the new forms of pathogens. Hence, filtration is an immense part involved in manufacturing of drugs. The drugs need to be protected against introduction of unwanted bacterias, virus and other micro-organisms and ensure patient safety.

Key Market Trends

Membrane Segment is Expected to Exhibit a Significant Market Growth in the Sterile Filtration Market

Membrane is a type of filter that have a uniform sized pores that traps the micro-organisms. The adoption of biologics, cell-culture based vaccines, etc. is growing, which is expected to grow the demand for filtration. For developing these biologics, cell filtration is a crucial part as the culture needs to be protected against introduction of unwanted bacteria, virus and other micro-organisms. Hence, a proper membrane filter is of utmost importance.

Furthermore, the clarification process involves centrifugation, microfiltration and harvesting of the culture. Cell separation and removal of cell debris are the primary goals of this procedure, for which membranes are required. Thus, it is expected to impact positively on the sterile filtration market.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to be a dominant region in the Sterile Filtration market, owing to the increasing number of API manufacturing facilities and increasing investment by companies into R&D activities. As per the data of US FDA (Food & Drug Administration), in 2019, approximately 510 API facilities were present in the United States. Furthermore, according to the Pharmaceutical Research & Manufacturers of America, in 2018, around 79.6 billion USD was invested by biopharmaceutical companies in R&D activities. Hence, the aforementioned factors are expected to boost the demand for sterile filtration.

Competitive Landscape

The well-known companies in Sterile Filtration market are Danaher Corporation, Merck KGaA, ThermoFisher Scientific Inc., Sartorius AG, GE Healthcare, 3M, Cole-Parmer Instrument Company, LLC, Sterlitech Corporation, Eaton Corporation and Porvair Filtration Group.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Chronic Diseases
    • 4.2.2 Rising Pharmaceutical & Biopharmaceutical Industry
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Sterile Filtration
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Cartridge Filter
    • 5.1.2 Capsule Filter
    • 5.1.3 Syringe Filter
    • 5.1.4 Other Membrane Filters
    • 5.1.5 Accessories
  • 5.2 By End User
    • 5.2.1 Pharmaceutical & Biopharmaceutical Companies
    • 5.2.2 Contract Research Organization
    • 5.2.3 Research Laboratories
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East & Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East & Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3M
    • 6.1.2 Cole-Parmer Instrument Company, LLC
    • 6.1.3 Danaher Corporation
    • 6.1.4 Eaton Corporation
    • 6.1.5 GE Healthcare
    • 6.1.6 Merck KGaA
    • 6.1.7 Sartorius AG
    • 6.1.8 Porvair Filtration Group
    • 6.1.9 Sterlitech Corporation
    • 6.1.10 ThermoFisher Scientific Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS